The major functions of the Study Design and Clinical Research Core are to (1) assist clinical and basic science investigators in digestive diseases with appropriate study design, statistical analyses, and data interpretation, and (2) assist these investigators in acquiring clinical specimens required for their digestive disease-related research. This Core has been highly productive and beneficial for members of the TMC Digestive Diseases Center. In the last 4 years, 22 Full Members used this Core as did 20 Associate members and Pilot and Feasibility (P/F) Awardees. Major Core services include providing study-design and statistical-analysis support;establishing procedures for data management and database organization to facilitate efficient analyses;assisting DDC investigators in acquiring clinical specimens needed for their research;assisting and training in compliance, patient confidentiality and oversight issues, including preparation of IRB requests and preparation of Investigational New Drug (IND) applications;and educating members via meetings and seminars. Each of the three Core Co-Directors brings a unique area of expertise in clinical and translational research, namely sample and tissue collection, epidemiology and health services research, and biostatistics. The three Core Co-Directors have a strong track record of collaborative work with investigators at the DDC, The UT-School of Public Health, Health Services Research Section at BCM, and The University of Texas M.D. Anderson Cancer Center. Advances during the past 4 years include the expansion of sample and tissue collection and banking, and the increased number of requests involving epidemiology and health outcomes research, especially those using electronic databases to capture large amounts of patient information, risk factors, therapies, and outcomes;these databases include large disease registries and healthcare claims data. The Clinical Core has been critically involved in developing the new human organoid (within the Integrative Biology Core) and microbiome services at the DDC. We anticipate the growth of demand for biological sample collections from basic and translational DDC investigators due to the increase in research using the Integrative Biology for organoid cultures and Microbiome Core. We also anticipate the growth of demand for expertise related to health services research in digestive diseases from newly recruited investigators and the newly funded T-32 NIDDK training program in epidemiology and outcomes of Gl diseases.

Public Health Relevance

This Core promotes the use of appropriate study design, statistical analyses and interpretation for clinical and basic science investigators. It helps investigators navigate the IRB process and can help obtain patient samples. A new emphasis offers assistance and training in disease registries and calims database and epidemiology and outcomes research needs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK056338-11
Application #
8474135
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (O2))
Project Start
Project End
Budget Start
2013-03-01
Budget End
2014-02-28
Support Year
11
Fiscal Year
2013
Total Cost
$172,150
Indirect Cost
$62,150
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Jiang, Zhi-Dong; Jenq, Robert R; Ajami, Nadim J et al. (2018) Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial. PLoS One 13:e0205064
Chumpitazi, Bruno P; Lim, Jongbin; McMeans, Ann R et al. (2018) Evaluation of FODMAP Carbohydrates Content in Selected Foods in the United States. J Pediatr 199:252-255
Mindikoglu, Ayse L; Opekun, Antone R; Putluri, Nagireddy et al. (2018) Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res 195:25-47
El-Serag, Hashem B (2018) Hospitalizations for Chronic Liver Disease: Time to Intervene at Multiple Levels. Gastroenterology 155:607-609
Wang, Zhensheng; White, Donna L; Hoogeveen, Ron et al. (2018) Anti-Hypertensive Medication Use, Soluble Receptor for Glycation End Products and Risk of Pancreatic Cancer in the Women's Health Initiative Study. J Clin Med 7:
Tayob, Nabihah; Richardson, Peter; White, Donna L et al. (2018) Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System. BMC Med Res Methodol 18:1
Vanga, Rohini R; Tansel, Aylin; Sidiq, Saad et al. (2018) Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 16:1220-1228.e4
Liang, Hong; Estes, Mary K; Zhang, Huiling et al. (2018) Bile acids target proteolipid nano-assemblies of EGFR and phosphatidic acid in the plasma membrane for stimulation of MAPK signaling. PLoS One 13:e0198983
Ganesh, Bhanu P; Nelson, James W; Eskew, Joshua R et al. (2018) Prebiotics, Probiotics, and Acetate Supplementation Prevent Hypertension in a Model of Obstructive Sleep Apnea. Hypertension 72:1141-1150
Szwarc, Maria M; Kommagani, Ramakrishna; Putluri, Vasanta et al. (2018) Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells. Sci Rep 8:13134

Showing the most recent 10 out of 1121 publications